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PI3K and MAPKs Regulate Neutrophil Migration Toward the
Airways in Heaves
M. Bullone, K. Moran, A. Lavoie-Lamoureux, and J.P. Lavoie
Background: Neutrophils accumulate in the airways of horses with heaves. They likely play an important role in the
disease pathogenesis. Understanding the pathways regulating their migration may help identifying new therapeutic targets.
Hypothesis: MAPK and PI3K pathways are involved in neutrophil migration toward the airway lumen in heaves.
Animals: Twelve heaves-affected horses and 4 healthy horses.
Methods: Migratory activity of bronchoalveolar lavage fluids (BALF) from horses with heaves and healthy horses was
compared by means of a Boyden chamber. Involvement of MAPK and PI3K pathways in neutrophil migration was inves-
tigated by pretreating neutrophils with inhibitors of p38 MAPK, JNK, MEK1/2, and PI3K. The capacity of a p38 MAPK
inhibitor at decreasing neutrophil chemotaxis toward the airways was also evaluated in vivo.
Results: BALF from symptomatic heaves-affected horses induced a greater degree of chemokinesis (P = .0004) than
BALF from healthy horses. Although all pathways tested were involved in neutrophil migration, inhibition of PI3K was
most potent in vitro. An inhibitor of p38 MAPK administered before challenge in horses with heaves did not alter BALF
chemokinetic properties. BALF neutrophil percentage and BALF migratory activity were positively correlated after 14 and
35 days of antigen challenge in healthy (P = .05; R2 = 0.82) and heaves-affected horses (P = .03; R2 = 0.76), respectively.
Conclusions and Clinical Importance: MAPK and PI3K pathways regulate neutrophil migration induced by BALF of
horses with heaves. Inhibition of multiple pathways might be required to completely abolish BALF-induced neutrophil
migratory activity and possibly inflammation in heaves.
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Neutrophils migrate toward sites of inflammationand infection where they act as early responder
cells toward the external insults. They are key actors
in host defense and also mediate tissue damage of vari-
ous noninfectious inflammatory processes. Neutrophils
accumulate in the airways of horses affected by heaves
starting few hours after their exposure to antigen-rich
environments.1 Within the airways, they likely contrib-
ute to bronchoconstriction, mucus hypersecretion, and
pulmonary remodeling by releasing proinflammatory
mediators, including TNF-a, MMPs, elastase, and
reactive oxygen species.2,3
Peripheral neutrophils adhere to endothelial cells
and migrate toward a gradient of stimuli (chemotaxis)
in a dose-dependent or independent manner in both
humans and horses. Mechanisms regulating their
recruitment in the tissues are complex and incom-
pletely understood.4 Bronchoalveolar fluids (BALF) of
heaves-affected horses have increased chemotactic activ-
ity when compared with that of healthy horses,
although this is not a constant finding.5,6 Indeed, sev-
eral chemoattractants including CXCL8, MIP-2, and
TNF-a7–9 are present in greater concentrations in the
airways of horses with heaves compared with normal
subjects during antigen challenge. However, it is not yet
clear which cells are mainly involved in synthesis and
release of these chemokines.
The ability of peripheral neutrophils to respond to
chemoattractants by migration is mediated by activa-
tion of several complex intracellular signaling path-
ways.10,11 Among those, mitogen-activated protein
kinases (MAPKs) and phosphoinositide-3 kinase
(PI3K) have been shown to be of primary importance
in neutrophil migratory activity.12 Expression of che-
motaxis-related pathways is usually studied in the pres-
ence of a single stimulus, which is clearly not what
occurs in vivo, where complex regulation of several cell
functions in response to multiple simultaneous media-
tors is required to maintain homeostasis. Furthermore,
the use of chemoattractants alone or in combination
might induce different effects on chemotaxis and its
regulatory mechanisms.13
The presence of neutrophils in the airways coincides
with exacerbation of the disease and possibly contrib-
utes to tissue damage and repair. Glucocorticoids are
anti-inflammatory drugs believed to inhibit neutrophil
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recruitment into the airways in heaves. Recently, our
group has shown that these drugs do not reverse luminal
neutrophilic inflammation, unless the antigenic stimu-
lus is withdrawn.14–16 Because of the poorly defined
role of neutrophils in pathogenesis of heaves, under-
standing the mechanisms underlying their migration
and accumulation in the airways could highlight
important therapeutic targets.
In this study, we explored several pathways possibly
involved in the recruitment of neutrophils toward the
airway lumen. We hypothesized that MAPKs and
PI3K contribute to the regulation of neutrophil migra-
tion in heaves. The aims of this study were to I) inves-
tigate differences in chemokinetic activity of BALFs
from heaves-affected and normal horses; II) examine
the effects of inhibitors of MAPKs and PI3K on neu-
trophil chemokinesis induced by BALFs from heaves-
affected horses in vitro; and III) study the effects of a




Sixteen mixed-breed healthy and heaves-affected horses from a
research herd were studied. All horses were stabled together and
regularly dewormed and vaccinated. During the 4 months preced-
ing the beginning of the study, horses had been pastured together
to ensure complete remission of the disease in the affected animals.
Horses undergoing antigen challenge were stabled, bedded on
straw, and fed hay twice a day.
Three additional horses (mean±SD, 501 ± 38 kg; 13 ± 2 year
old) from a teaching herd considered healthy based on clinical
examination and hematology findings were used as donors of
neutrophils. They were regularly vaccinated and dewormed, and
had no history of drug administration within the last month.
The experimental protocol was performed in accordance with
the guidelines for the Canadian Council on Animal Care and was
approved by the Animal Care Committee of the Faculty of Vet-
erinary Medicine of the Universite´ de Montre´al.
Respiratory Function Test
Respiratory mechanics were performed on unsedated horses as
previously described.17 Respiratory flow rates were measured
with a heated pneumotachograph. Transpulmonary pressures
(DPL) were measured with a balloon sealed over the end of a
polyethylene catheter placed in the distal third of the esophagus.
All input signals were analyzed by a dedicated data acquisition
and analysis software.a Values of pulmonary resistance (RL) and
elastance (EL) were also obtained for each breath by applying the
multiple regression equation for the single compartment model of
the lung.
Bronchoalveolar Lavage
BALs were performed on horses sedated with xylazineb and
butorphanolc (IV dose) as previously described.18 Briefly, a fiber-
optic endoscope was introduced into a nostril and advanced until
it wedged in a bronchus. Two boluses (250 mL) of sterile pre-
warmed (37°C) isotonic saline solution were sequentially infused
and aspirated with a suction pump. BAL fluids were filtered
through sterile gauze, centrifuged at 4°C and supernatant stored
at 80°C until chemotactic assays were performed. The total cell
count was determined with a hemacytometer and differential cell
counts were performed on cytospin preparationsd following
Wright Giemsa staining. A minimum of 400 cells were counted
for each sample.
Neutrophil Isolation
Blood was collected in heparinized tubese by jugular venipunc-
ture from healthy horses. Neutrophils were isolated from periph-
eral blood by lympholyte-poly density gradient centrifugation.f
Neutrophils were resuspended in PBS containing Ca2+ (1 mM),
Mg2+ (1 mM), and 0.5% BSA to obtain a final concentration of
5 9 106 cells/mL). The total neutrophil count was determined
with a hemacytometer, and cell viability was assessed by a Try-
pan blue dye exclusion test. Neutrophils were used for chemotac-
tic assays if they demonstrated greater than 95% purity and 98%
viability.
Neutrophil Pretreatment with Pharmacological
Inhibitors
MAPKs, PI3K, and c-Jun N-terminal kinase (JNK) inhibitors
were used to study the signaling pathways involved in neutrophil
migration induced by BALFs of heaves-infected horses. Neu-
trophils isolated from healthy horses were pretreated with
SB203580g (3 lM), SP600125h (15 lM), and PD98059i (50 lM)
to block p38 MAPK, JNK, and MEK1/2, respectively. Wort-
manninj (100 nM) was used to block PI3K. Neutrophils were
pretreated with all inhibitors for 1 hour at 37°C. Effective con-
centrations of all inhibitors were selected according to data
obtained in preliminary experiments performed on equine neu-
trophils, to validate concentrations used in previous studies (data
available online).
Chemokinetic Assays
Chemokinetic activity of BALFs on neutrophils was measured
with 48-well microchemotaxis chambers.k,19 The lower wells were
filled with 30 lL of the chosen chemoattractant. They were then
overlaid with Sartorius cellulose nitrate filtersl (8-lm pore size,
140-lm thick) premoistened with PBS containing Ca2+ (1 mM),
Mg2+ (1 mM), and 0.5% BSA. The same solution was used in the
lower wells as negative control in preliminary tests (data not
shown). Aliquots of 55 lL of pretreated or untreated neutrophils
suspension (1.5 9 105 cells in the comparative experiment
between healthy and heaves horses, 2.75 9 105 cells in all other
experiments) were then added over each well. The chambers were
incubated for 1 hour at 37°C in 5% CO2 and humidified air. The
filters were harvested, fixed with mercuric chloride, and stained
with hematoxylinm and Chromotrope 2R.n,20 Then, they were
dehydrated, cleared, and counted as described elsewhere.21 Chem-
okinetic activity of BALFs was determined by counting the num-
ber of neutrophils on the lower side of the filter, with a light
microscope and an eyepiece graticule to facilitate the counting.
Five distinct fields were counted at high magnification (400 9 ).
All chemotactic assays were performed as triplicates. Mean values
of triplicates were reported and used for statistical examinations.
Experimental Protocol
Part 1. Five heaves-affected horses (460 ± 15 kg, 15 ± 4 year
old) and 4 control horses (491 ± 85 kg, 12 ± 3 year old) were
exposed to antigen challenge for 35 days. Migratory activities of
BALFs obtained from the 2 groups at T35 were measured in vitro.
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BALFs collected at T35 from the 5 heaves-affected horses were
employed in chemokinetic assays to assess the involvement of
selected kinase inhibitors in regulating equine neutrophil migra-
tion.
Part 2. Ten asymptomatic heaves-affected horses (500 ± 38 kg;
13 ± 2 year old) were exposed to antigen challenge for 14 days.
Three horses had participated in study 1; a minimum of 8-week
washout period was observed between the studies. During the
14 days of antigen exposure, 5 horses were treated with a p38
MAPK inhibitor as previously reported by Lavoie,22 whereas 5
horses were used as untreated controls. Briefly, the MRL-EQ1
compound was administered IV twice a day at decreasing dos-
ages (1.5 mg/kg for 3 days; 1 mg/kg for 6 days; and 0.75 mg/kg
for 5 days). BALs were performed before and after the treatment
period (T0 and T14). Percentage of neutrophils in BALF was
measured and chemokinetic assays were performed to assess
migratory activity of BALFs collected at the different time
points.
Statistical Analysis
The effects of antigen challenge and group (heaves versus con-
trol) on transpulmonary pressure and neutrophil percentage in
BALF, and the in vitro inhibition of neutrophil migrations with
pharmacological agents, were analyzed with repeated-measure
mixed linear models with a priori contrasts and sequential Bon-
ferroni correction with SAS v.9.1.o All other data were analyzed
by GraphPad Prism 5 Software.p An unpaired t-test was used to
analyze data from the comparative studies of control and heaves-
affected horses or in vivo p38 MAPK inhibitor-treated and
untreated horses. One-tailed Pearson tests were used to correlate
neutrophil percentage in BALF and BALF-induced neutrophil
migratory activity as higher chemotactic activity was expected in
BALF with greater percentage of neutrophils. Graphs show raw
data, expressed as mean ± standard deviation [SD]. P values less
than .05 were considered as statistically significant.
Results
PI3K Pathway
Horses from both groups had normal lung function
(ΔPL<10 cmH2O) and no airway inflammation (neu-
trophils <5%, mast cells <2%, eosinophils <1%) while
at pasture. Horses with heaves developed airway
obstruction and a greater bronchial luminal neutro-
philia (P = .005) compared with controls when chal-
lenged (Fig 1). BALF from heaves-affected horses
induced a significantly greater (approximately 3-fold)
migration of neutrophils compared with BALF from
healthy horses (P = .0004, Fig 2). The percentages
of neutrophils in BALF correlated positively with
BALF migratory activity at T35 in healthy horses
(P = .05, R2 = 0.82), but not in horses with heaves
(P = .18; R2 = 0.27). All inhibitors studied significantly
decreased the chemokinesis of equine neutrophils trig-
gered by BALF collected from heaves-affected horses
(Fig 3). Wortmannin (100 nM), a PI3K inhibitor, was
most potent at decreasing neutrophil migration
(P  .002) compared with other inhibitors tested.
Blocking both p38 MAPK and MEK1/2 had stronger
inhibitory effects than blocking p38 MAPK (P = .0004)
alone, but not MEK1/2. Therefore, the combination of
p38 MAPK and MEK1/2 inhibitors showed at most
an additive effect on BALF-induced neutrophil chemo-
kinesis.
MAPK Pathway
BALF-induced migration of neutrophils was not
significantly different in the 2 groups of heaves-
affected horses at T0 (data not shown). Administra-
tion of a p38 MAPK inhibitor did not reduce BALF
migratory activity at T14 when compared with BALF
migratory activity of untreated heaves-affected horses
at the same time (Fig 4). The percentage of neutroph-
ils in BALF and BALF migratory activity was posi-
tively correlated in untreated horses (P = .03,
R2 = 0.76), but not in p38 MAPK inhibitor-treated
horses (P = .35, R2 = 0.03).
Discussion
Using BALF supernatants from antigen challenged
heaves-affected horses as a chemokinetic compound in
our experiments, we demonstrated that both MAPK and
PI3K pathways are involved in regulating airway
neutrophil migratory activity in vitro, with the latter
being most potent. The methodology we employed mea-
sures generalized increase in the migratory activity of
neutrophils (chemokinesis), but did not allow to
differentiate between chemotaxis and chemokinesis. The
previously reported reduction in neutrophil percentages
in BALF with the administration of a p38MAPK inhibi-
tor to horses with heaves22 was likely caused by a reduc-
tion of peripheral blood neutrophil ability to migrate,
given the unchanged BALF migratory activity observed
in this study. Taken together, these results suggest that
multiple signaling pathways contribute to airway neutro-
philia in this disease, but that PI3K might represent an
effective target for the control of inflammation in heaves.
The accumulation of neutrophils within the airway
lumen likely plays a central role in the clinical and
pathological features of equine heaves. Drugs prevent-
ing neutrophil chemotaxis toward the airways could
thus represent novel tools for the control of this dis-
ease. Studies using both human and animal neutroph-
ils have attempted to clarify which pathways regulate
their migration toward the airway lumen.23–27 In vitro
studies generally use single chemoattractants to evalu-
ate the possible contribution of several pathways to
cell migration. Interestingly, the stimuli used to stimu-
late neutrophil chemotaxis in vitro elicit different
responses when applied separately or simultaneously,
as a consequence of the ability of several enzymatic
pathways to regulate each other once activated.13,28
Thus, a chemotactic stimulus as similar as possible to
that present in vivo is more likely to yield results lead-
ing to effective treatment.
Several molecules, including chemokines, cytokines,
and eicosanoids, have been identified in greater con-
centrations in BALF of heaves-affected horses com-
pared with normal horses. CXCL8, LTB4, and MIP-2
are three of the most potent chemoattractants synthe-
sized by neutrophils and other cells that have been
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associated with heaves.29–34 IL-4 and TNF-a also con-
tribute to recruitment and retention of neutrophils into
inflammatory sites.35,36 TNF-a induces an increase in
the expression of the adhesion molecule ICAM-1 in
both human endothelial and bronchial epithelial cells
in vitro, which may foster local neutrophil influx in
vivo.37–39 Given the nature and concentration of the
molecules detected in BALF from heaves-affected
horses, it is not surprising that our experiments, in
agreement with previous reports,6,40,41 showed an
increased migration of neutrophils toward BALF from
heaves-affected horses compared with healthy horses.
MAPKs are serine/threonine-specific protein kinases
activated by different extracellular stimuli following a
cascade mechanism. MEK1/2 is one of the kinases that
activate MAPKs. The MAPKs subfamilies include the
extracellular signal-regulated kinases (ERK), further
subclassified as ERK1/2, ERK3/4, ERK5 and ERK6/
7, the c-Jun NH2-terminal kinases (JNK), and the p38
MAPK, of which ERK1/2, JNK, and p38 MAPK are
expressed in neutrophils.12,42 The p38 MAPK pathway
has been shown to regulate proinflammatory angiogen-
esis, cytokine and chemokine expression, and synthesis
A B
Fig 1. Effects of antigen challenge on lung function (A) and inflammation (B) in controls (n = 4) and heaves-affected horses (n = 5).
A 35-day period (T35) of antigen challenge induced a significant increase in percentage of BALF neutrophils and maximal change in
transpulmonary pressure (DPL) only in heaves-affected horses.
A
B C
Fig 2. Migratory properties of BALF from heaves-affected
(n = 5) and control (n = 4) horses. BALFs collected from horses
with heaves after 35 days of antigen challenge induced a signifi-
cantly greater neutrophil chemokinesis in vitro, compared with
BALF from healthy horses kept in the same environment (A).
Representative microphotographs of neutrophil migration
induced by BALF of healthy (B) and heaves-affected horses (C).
Hematoxylin and Chromotrope 2R, 40x.
Fig 3. Inhibition of neutrophil migration by kinase inhibitors in
vitro. BALF were collected from horses with heaves after 35 days
of antigen challenge. White: untreated; black: treated. *P < .001; #:
significantly greater than all other inhibitors tested (P  .002).
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by local cells and neutrophils in the lung.36,43–46 PI3Ks
are a family of intracellular kinases activated by a
number of molecules and stressing events for the cell.
They are involved in regulation of cellular prolifera-
tion, cell cycle, differentiation, apoptosis, and gene
expression.2,42,47 Recent findings suggest that the
nature of the stimuli determines which of the above
pathways is primarily involved in chemotaxis activa-
tion. Indeed, PI3K pathway activation has been linked
to “intermediary chemoattractant”-induced migration,
whereas the p38 MAPK pathway is activated by “end-
target chemoattractants”. Based on this theory, LTB4,
CXCL8, and PAF have been classified as intermediary,
whereas other molecules like TNF-a, fMLP, and C5a
are end-target chemoattractants. Interestingly, all
chemoattractants separately can activate PI3K in vitro,
while when they are present simultaneously, p38
MAPK activation predominates, suggesting that the
latter can suppresses PI3K activity.28 However, in our
experiments, although all MAPK pathways were
activated (given the significant decrease in migratory
activity that we observed after MAPKs inhibition),
PI3K was the major pathway involved in BALF-
induced equine neutrophil chemokinesis in vitro. In
support of our findings, horses exposed to antigen
challenge and simultaneously treated with a p38
MAPK inhibitor were reported to have lower percent-
age of neutrophils in BALF compared with untreated
horses,22 although airway neutrophilia persisted in
treated horses. Taken together, these findings suggest
that p38 MAPK contributes to neutrophil migration
both in vitro and in vivo, but may not be the primary
pathway involved in heaves. The pivotal role of class I
PI3Ks in regulation of neutrophil migration is well
known, although its inhibition cannot completely
avoid neutrophil motile activity.48,49 Accordingly, our
data show a large, yet not complete, reduction in neu-
trophil migration toward the migratory stimulus when
cells were pretreated with the PI3K-inhibitory
compound Wortmannin. These observations support
Wortmannin or other PI3K inhibitors as new potential
treatments to control bronchial inflammation in
heaves.
In vitro neutrophil chemotaxis toward a gradient of
stimuli is mainly dependent on the motile machinery,
in which actin filament activation and polarization
represent the central events. In vivo, neutrophil
chemotaxis from the vessels to the tissues starts with
rolling and subsequent adhesion of the cells to the
endothelium, followed by extravasation and migration
toward the stimuli. Our results support an effect of
p38 MAPK inhibition mainly on intrinsic migratory
capacity of neutrophils or on their adhesion process to
the endothelium.11,25 Indeed, after blocking p38 MAPK
activity, neutrophil chemokinesis was decreased in
vitro. Neutrophil recruitment into the airway lumen
was decreased as well, and the lack of a concomitant
decrease in BALF migratory activity suggests that the
concentration of chemoattractants in BALF was not
significantly affected by the treatment administered.
Alternatively, the overall contribution of this pathway
may be small and drug effects could have been masked
by other more potent chemotactic factors.22 In support
of this hypothesis, inhibition of p38 MAPK signifi-
cantly decreased equine neutrophil polarization and
adhesion in response to LTB4 and PAF, and TNF-a,
respectively.11
Neutrophils synthesize chemoattractant molecules
and they are found in great quantity in airways of
horses with heaves. Correlation between neutrophil
percentage in BALF and BALF migratory activity
varied in the different groups of horses and at the dif-
ferent time points evaluated. Indeed, a positive correla-
tion between these 2 parameters was present in healthy
horses after stabling, whereas a positive correlation
was detected at T14 in horses with heaves, but not at
T35. The lack of correlation at T35 might be attribut-
able in part to the great variability of data collected in
this group of horses, or to the fact that different sub-
sets of cytokines and chemokines could be synthesized
and present into the airway lumen at the 2 time points
studied, which might elicit a different migratory
response by neutrophils. Alternatively, the neutrophil
migration rate may be maximum after 14 days of anti-
gen challenge and a further increase in chemotactic sig-
naling may not be accompanied by an augmented
neutrophil influx into the bronchial lumen.
In conclusion, our results indicate that neutrophil
influx toward the airways in heaves is regulated by
both MAPK and PI3K pathways, which can poten-
tially control different cell functions related to chemo-
taxis other than those regulating the migratory
processes per se (ie, production of chemoattractants).
A p38 MAPK modulation of cytoskeleton processes,
as previously suggested,11 could possibly explain the
combined reduced percentages of neutrophils in BALF
and unaltered BALF chemotactic activity observed
with the administration of a p38 MAPK inhibitor in
horses with heaves. Blocking PI3K had a profound
inhibitory effect on neutrophil chemotaxis in vitro;
Fig 4. BALF migratory activity after 14 days of antigen chal-
lenge and simultaneous in vivo treatment with p38 MAPK inhibi-
tor. BALF collected from heaves-affected horses receiving
systemic treatment (n = 5) had a chemokinetic activity not signifi-
cantly different compared with BALF from untreated heaves-
affected horses (n = 5; P = .111).
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inhibition of this pathway might represent a new target
for the control of airway neutrophilia in heaves.
Footnotes
a Anadat, RHT-Infodat, Montreal, QC, Canada
b Rompun 100 mg/mL, Bayer Healthcare, Toronto, ON, Canada
c Torbugesic, Pfizer Animal Health, Kirkland, QC, Canada
d Cytospin model II, Shandon Southern Instruments, Sewickley,
PA
e BD Vacutainer Tubes, BD, Franklin Lakes, NJ
f Lympholyte, Cedarlane Laboratory Limited, Burlington, ON,
Canada
g SB203580, Cedarlane Laboratory Limited
h SP600125, Cedarlane Laboratory Limited
i PD98059, Cedarlane Laboratory Limited
j Wortmannin, Sigma-Aldrich Canada Ltd, Oakville, ON, Canada
k AP48 Chemotactic Chamber, Neuro Probe Inc, Gaithersburg, MD
l SCB8 Cellulose Nitrate Filters, Neuro Probe Inc
m Hematoxylin, VWR International, Ville Mont-Royal, QC, Canada
n Chromotrope 2R, Sigma-Aldrich Canada Ltd
o SAS v.9.1, Cary, NC
p GraphPad Software Inc, La Jolla, CA
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